ERGO (Entia Biosciences) Asset Turnover: 0.11 (As of Dec. 2016)


What is Entia Biosciences Asset Turnover?

Entia Biosciences ERGO Asset Turnover is 0.11 as of Dec. 2016.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Entia Biosciences's Revenue for the three months ended in Dec. 2016 was $0.05 Mil. Entia Biosciences's Total Assets for the quarter that ended in Dec. 2016 was $0.40 Mil. Therefore, Entia Biosciences's Asset Turnover for the quarter that ended in Dec. 2016 was 0.11.

Asset Turnover is linked to ROE % through Du Pont Formula. Entia Biosciences's annualized ROE % for the quarter that ended in Dec. 2016 was 95.93%. It is also linked to ROA % through Du Pont Formula. Entia Biosciences's annualized ROA % for the quarter that ended in Dec. 2016 was -430.31%.

Entia Biosciences  (OTCPK:ERGO) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Entia Biosciences's annulized ROE % for the quarter that ended in Dec. 2016 is

ROE %**(Q: Dec. 2016 )
=Net Income/Total Stockholders Equity
=-1.732/-1.8055
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.732 / 0.184)*(0.184 / 0.4025)*(0.4025/ -1.8055)
=Net Margin %*Asset Turnover*Equity Multiplier
=-941.3 %*0.4571*-0.2229
=ROA %*Equity Multiplier
=-430.31 %*-0.2229
=95.93 %

Note: The Net Income data used here is four times the quarterly (Dec. 2016) net income data. The Revenue data used here is four times the quarterly (Dec. 2016) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Entia Biosciences's annulized ROA % for the quarter that ended in Dec. 2016 is

ROA %(Q: Dec. 2016 )
=Net Income/Total Assets
=-1.732/0.4025
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.732 / 0.184)*(0.184 / 0.4025)
=Net Margin %*Asset Turnover
=-941.3 %*0.4571
=-430.31 %

Note: The Net Income data used here is four times the quarterly (Dec. 2016) net income data. The Revenue data used here is four times the quarterly (Dec. 2016) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Entia Biosciences Asset Turnover Related Terms

Entia Biosciences Asset Turnover Historical Data

* Premium members only.

The historical data trend for Entia Biosciences's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entia Biosciences Asset Turnover Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.58 0.87 0.53 0.60

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.19 0.24 0.11 0.11

ERGO vs OBMP, NSPX, ATRX: Asset Turnover Comparison

For the Biotechnology subindustry, Entia Biosciences's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entia Biosciences Asset Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entia Biosciences's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Entia Biosciences's Asset Turnover falls into.


Entia Biosciences Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Entia Biosciences's Asset Turnover for the fiscal year that ended in Dec. 2016 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2016 )/( (Total Assets (A: Dec. 2015 )+Total Assets (A: Dec. 2016 ))/ count )
=0.265/( (0.449+0.439)/ 2 )
=0.265/0.444
=0.60

Entia Biosciences's Asset Turnover for the quarter that ended in Dec. 2016 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2016 )/( (Total Assets (Q: Sep. 2016 )+Total Assets (Q: Dec. 2016 ))/ count )
=0.046/( (0.366+0.439)/ 2 )
=0.046/0.4025
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.11 mean?
Entia Biosciences (ERGO) has a Asset Turnover of 0.11 as of Dec. 2016. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Entia Biosciences and its competitors.
Is Entia Biosciences' Asset Turnover too high?
Entia Biosciences' current Asset Turnover is 0.11.
How does Entia Biosciences' Asset Turnover compare to OBMP and NSPX?
Entia Biosciences' Asset Turnover of 0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Biotechnology company?
A good Asset Turnover depends on the Biotechnology industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Entia Biosciences and its competitors. Entia Biosciences's current Asset Turnover is 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current Asset Turnover of 0.11. The current Asset Turnover is 0.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current Asset Turnover is 0.11 as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entia Biosciences Business Description

Address 13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.